Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
about
Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4Redox mechanisms in hepatic chronic wound healing and fibrogenesisFuture imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomographyModulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsNovel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?Transcriptome Profiling Reveals Disruption of Innate Immunity in Chronic Heavy Ethanol Consuming Female Rhesus MacaquesSpiral ligament fibrocyte-derived MCP-1/CCL2 contributes to inner ear inflammation secondary to nontypeable H. influenzae-induced otitis media.IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.Seminal plasma induces global transcriptomic changes associated with cell migration, proliferation and viability in endometrial epithelial cells and stromal fibroblastsLigand supported homology modeling and docking evaluation of CCR2: docked pose selection by consensus scoring.Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia.Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways.Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.MCP-1 contributes to arteriovenous fistula failure.Doxycycline decreases monocyte chemoattractant protein-1 in human lung epithelial cells.Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient miceGender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells.IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.Early activated hepatic stellate cell-derived molecules reverse acute hepatic injuryTranscriptional modulation of intestinal innate defense/inflammation genes by preterm infant microbiota in a humanized gnotobiotic mouse modelDiscovery, optimization, and pharmacological characterization of novel heteroaroylphenylureas antagonists of C-C chemokine ligand 2 functionCritical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sitesLeishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitisA randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair.Deep sequencing of the uterine immune response to bacteria during the equine oestrous cycle.Therapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental Atherosclerosis.Renaming cytokines: MCP-1, major chemokine in pancreatitisChemokines: integrators of pain and inflammation.Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokinesA randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis.Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotypec-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene.MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult.Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes
P2860
Q24310573-B73C9F8D-6F48-4143-9011-709C56FB3454Q24543690-68C61005-BD8B-4FE8-8C68-FFB4F4E77FACQ24656684-76F433D8-6958-4D35-9D51-A3654701A13AQ26738576-08D53E33-F8FE-49B3-BC4D-157DF44BC6C2Q26800158-65B7B43C-DECA-413C-A4EA-F7AA92DB713BQ27005674-3FCBB349-F9EE-4615-BCDE-4D5E6DF57C05Q27334505-4478C759-AA04-4166-9186-4A1AE4C0BBDBQ30478615-EF4679E6-4C52-4477-9015-08B1EE4C0FACQ33405619-EC691781-4B90-4E87-B004-3E5A385E61E6Q33598471-6843D54D-2282-4E31-98E6-DCB8B39566FFQ33787996-3244241E-5059-4B29-9F46-947350730AF8Q33825672-D358C686-28E4-40C7-BB21-38777C462AD5Q33880596-C222AB88-EBCC-4029-AD87-E0932F7567D7Q34166698-50B5CE57-42E3-41FD-B3BC-4E9B7E89EC79Q34249533-CE609050-DC7C-4426-8674-562EAA9164CCQ34457225-3DD9F462-754C-495F-BB52-1D57F2422DF0Q34543026-415539A1-5BBB-4549-8BEC-D952DB91F9FAQ34602053-47CDCB09-30A7-45EE-B0EB-144E0670C873Q34735060-82F5EF60-18D6-4833-9DEA-1978FF4BBEBCQ34983577-F26AF291-6D11-4B2B-AA20-329E17C077DFQ35096050-4DF7C688-0209-49D4-9214-5F82B600D46AQ35156105-EB2C0D01-3C59-4AD9-B161-F560A27FCD22Q35250952-B27AAB0D-5023-4327-ACB3-B9ED2388C681Q35375422-A47D4D96-43A9-4CA8-B2AB-1823851AEB10Q35557642-F89B30C3-814B-47E1-A5F9-2A5B86AA3E7FQ35588337-79CD186F-F163-4004-8F42-B3C8EE8F8601Q35664094-532A19FF-F200-4F5C-9D5A-AE8FECF2058EQ35689327-8B570470-10EB-4DE5-9EB3-ADE78EE002E9Q35769489-2DBFB5C3-E248-4B65-A7E0-0B9726ECAC24Q35776294-49BBF5C8-15CA-455B-9252-014E99FB18ECQ35842486-08902B46-2BE1-483B-A5C9-CC4E8913333EQ35913344-54CC0E7A-B6AE-4397-9213-3EE578335B2EQ36164454-55829BCE-86CE-4521-9FAB-5DFCC31764DDQ36285939-9C7AB509-1FF6-4483-9254-7C20387B452DQ36389337-230A05F9-ED57-4FC8-A659-EBEB8FDE2E8AQ36516482-90317A2B-0232-409F-9554-D961BE938001Q36570240-15DAC7D3-9DBD-4310-800C-4220F286D499Q36748131-7286262E-E6DF-4479-B942-FAECD7A0F2CBQ36857314-25618908-F29B-4E72-A29C-C5BBC016F372Q36943742-131E9908-ADC2-484A-8BA1-43764825015C
P2860
Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Monocyte chemoattractant prote ...... portunities and controversies.
@ast
Monocyte chemoattractant prote ...... portunities and controversies.
@en
type
label
Monocyte chemoattractant prote ...... portunities and controversies.
@ast
Monocyte chemoattractant prote ...... portunities and controversies.
@en
prefLabel
Monocyte chemoattractant prote ...... portunities and controversies.
@ast
Monocyte chemoattractant prote ...... portunities and controversies.
@en
P1433
P1476
Monocyte chemoattractant prote ...... portunities and controversies.
@en
P2093
Barrett J Rollins
Christine Daly
P304
P356
10.1080/MIC.10.3-4.247.257
P577
2003-06-01T00:00:00Z